Background. The purpose of this study was to review the authors’ experience of fat grafting, evaluating the effects related to the use of fat grafting with platelet-rich plasma (PRP) in the improvement of fat volume in breast reconstruction and comparing the results with a control group (only centrifuged fat grafting). Methods. A total of 50 patients aged between 19 and 60 years affected by breast soft-tissue defects were analyzed at the Plastic and Reconstructive Department of the University of Tor Vergata. They were treated with fat grafting + PRP. The control group (50 patients with breast soft-tissue defects) were treated with centrifuged fat grafting injection according to Coleman’s procedure. Results. The patients treated with PRP added to the autologous fat grafts showed a 69% maintenance of the contour restoring and of 3-dimensional volume after 1 year, whereas the patients of the control group treated with centrifuged fat grafting showed a 39% maintenance. Conclusion. PRP mixed with fat grafting leads to an improvement in maintaining breast volume in patients affected by breast soft-tissue defects.
RigottiGMarchiAGalieM. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007;119:1409-1422; discussion 1423-1404.
2.
YoshimuraKSatoKAoiNKuritaMHirohiTHariiK. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg. 2008;32:48-55; discussion 56-57.
3.
RigottiGMarchiAStringhiniP. Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesthetic Plast Surg. 2010;34:475-480.
4.
YoshimuraKAsanoYAoiN. Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J. 2010;16:169-175.
5.
LendeckelSJodickeAChristophisP. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg. 2004;32:370-373.
6.
CantarellaGMazzolaRFDomenichiniE. Vocal fold augmentation by autologous fat injection with lipostructure procedure. Otolaryngol Head Neck Surg. 2005;132:239-243.
7.
ColemanSR. Facial recontouring with lipostructure. Clin Plast Surg. 1997;24:347-367.
CervelliVGentilePScioliMG. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods. 2009;15:625-634.
10.
CervelliVGentilePGrimaldiM. Regenerative surgery: use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast Surg. 2009;33:340-345.
11.
CervelliVGentileP. Use of cell fat mixed with platelet gel in progressive hemifacial atrophy. Aesthetic Plast Surg. 2009;33:22-27.
12.
PetitJYLohsiriwatVCloughKB. The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study—Milan-Paris-Lyon experience of 646 lipofilling procedures. Plast Reconstr Surg. 2011;128:341-346.
13.
PulagamSRPoultonTMamounasEP. Long-term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature. Breast J. 2006;12:63-65.
14.
KwakJYLeeSHParkHLKimJYKimSEKimEK. Sonographic findings in complications of cosmetic breast augmentation with autologous fat obtained by liposuction. J Clin Ultrasound. 2004;32:299-301.
15.
GutowskiKA; ASPS Fat Graft Task Force. Current applications and safety of autologous fat grafts: a report of the ASPS fat graft task force. Plast Reconstr Surg. 2009;124:272-280.
16.
LinKMatsubaraYMasudaY. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy. 2008;10:417-426.
17.
RehmanJTraktuevDLiJ. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292-1298.
18.
KevySVJacobsonMS. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol. 2004;36:28-35.
19.
ArmDM. Autologous platelet-based therapies for orthopaedic tissue regeneration. Orthopedics. 2002;25:169.
20.
WatersJHRobertsKC. Database review of possible factors influencing point-of-care platelet gel manufacture. J Extra Corpor Technol. 2004;36:250.
21.
ManDPloskerHWinland-BrownJE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:229-237.
22.
LozadaJLCaplanisNProussaefsP. Platelet-rich plasma application in sinus graft surgery: part I. Background and processing techniques. J Oral Implantol. 2001;27:38-42.
23.
HoodAGArmDM. Topical application of autogenous tissue growth factors for augmentation of structural bone graft fusion. Paper presented at: American Society of Extra-Corporeal Technology 11th Annual Symposium on New Advances in Blood Management; April 20-23, 2004; Las Vegas, NV.
24.
FraserJKHedrickMHCohenSR. Oncologic risks of autologous fat grafting to the breast. Aesthet Surg J. 2011;31:68-75.
25.
AnituaESánchezMNurdenAT. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A. 2006;77:285-293.
26.
MazzuccoLBalboVCattanaEGuaschinoRBorziniP. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang. 2009;97:110-118.
27.
CaoYSunZLiaoLMengYHanQZhaoRC. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332:370-379.
28.
ZhuMZhouZChenY. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg. 2010;64:222-228.
29.
StrawfordAAnteloFChristiansenMHellersteinMK. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. Am J Physiol Endocrinol Metab. 2004;286:E577-E588.
30.
CitriAYardenY. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006;7:505-516.
31.
ColwellASDamjanovicBZahediBMedford-DavisLHertlCAustenWGJr.. Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg. 2011;128:1170-1178.
32.
SbitanyHSerlettiJM. Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity. Plast Reconstr Surg. 2011;128:1162-1169.
33.
KimJYDavilaAAPersingS. A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction. Plast Reconstr Surg. 2012;129:28-41.
34.
HoppeICYuehJHWeiCHAhujaNKPatelPPDatiashviliRO. Complications following expander/implant breast reconstruction utilizing acellular dermal matrix: a systematic review and meta-analysis. Eplasty. 2011;11:e40.
35.
SalgarelloMViscontiGRuscianiA. Breast fat grafting with platelet-rich plasma: a comparative clinical study and current state of the art. Plast Reconstr Surg. 2011;127:2176-2185.
36.
NeremRSageHKelleyCAMcNicolLA. Symposium summary. Ann N Y Acad Sci. 2002;961:386-389.
37.
Oedayrajsingh-VarmaMJvan HamSMKnippenbergM. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8:166-177.
38.
Prunet-MarcassusBCousinBCatonDAndreMPenicaudLCasteillaL. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res. 2006;312:727-736.
39.
GimbleJMKatzAJBunnellBA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249-1260.
40.
CervelliVGentilePDe AngelisB. Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcers. Stem Cell Res. 2011;6:103-111.
41.
NedelecBShankowskyHATredgetEE. Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil. 2000;21:205-212.
42.
SchneiderMRWolfE. The epidermal growth factor receptor ligands at a glance. J Cell Physiol. 2009;218:460-466.
43.
PaganoECalvoJC. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes. J Cell Biochem. 2003;90:561-572.
